Hellenic Cooperative Oncology Group | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

42,663 results for “Hellenic Cooperative Oncology Group”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy: a Hellenic Cooperative Oncology Group (HeCOG) Study.

5,358 participants · First posted Apr 9, 2026

HNSCC Immuno-genomics Project

401 participants · First posted Dec 10, 2024

Osimertinib as 1st Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer

40 participants · First posted Nov 19, 2021

Checkpoint Inhibitors in Patients With Cancer and Underlying Autoimmune Disease

126 participants · First posted Mar 18, 2021

Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors

82 participants · First posted Oct 11, 2010

Real-world Data in Patients With Breast Cancer Treated With Abemaciclib

108 participants · First posted Aug 2, 2021

Clinico-pathological and Genomic Features of HER2-low Early Breast Cancer

3,648 participants · First posted May 1, 2026

Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse

9 participants · First posted Jun 23, 2009

Survival Analysis of Early TNBC Women Treated With Dose Dense Sequential Adjuvant Chemotherapy

3,648 participants · First posted Sep 15, 2026

Adjuvant Chemotherapy With Epirubicin, CMF, and Weekly Docetaxel or Weekly Paclitaxel in Patients With Resected High-risk Breast Cancer

89 participants · First posted Apr 2, 2021

Page 1 of 2680